Pterostilbene: Resveratrol Analog with Superior Bioavailability for Cardiovascular & Cognitive Health
⚡ 60-Second Summary
Pterostilbene (trans-3,5-dimethoxy-4'-hydroxystilbene) is a stilbenoid polyphenol found primarily in blueberries, grapes, and Pterocarpus marsupium bark. Its two methoxy groups (compared to resveratrol's two hydroxyls) make it more lipophilic and resistant to phase II metabolism, resulting in dramatically superior oral bioavailability (~80% in animal models vs. resveratrol's <1%).
Best-evidenced properties: blood pressure reduction (human RCT showing significant systolic BP reduction), LDL and total cholesterol reduction (human trial data), cognitive function (BDNF upregulation and antioxidant mechanisms in animal studies with early human signals), and AMPK activation (the longevity pathway activated by caloric restriction and metformin).
Pterostilbene is often marketed as 'better resveratrol' — while the bioavailability advantage is real and significant, human clinical evidence for pterostilbene specifically is much more limited than for resveratrol. The comparison is mechanistically compelling but clinically unproven.
What is Pterostilbene?
Pterostilbene was isolated from Pterocarpus marsupium (Indian Kino tree) in the 1970s, but gained supplement attention in the early 2000s through blueberry antioxidant research. It rose to prominence in the longevity supplement space primarily through David Sinclair's sirtuin activation research, which identified both resveratrol and pterostilbene as stilbene polyphenols with SIRT1-activating properties.
The commercially used form is synthetic trans-pterostilbene, which is chemically identical to the naturally occurring compound but produced at supplement-relevant quantities.
Evidence-based benefits
Blood Pressure Reduction
A randomized, double-blind, placebo-controlled trial (Riche et al., 2013, Journal of Clinical Pharmacy and Therapeutics) of 80 subjects showed pterostilbene 50 mg twice daily significantly reduced systolic blood pressure (-7.8 mmHg) versus placebo over 6–8 weeks. This is the primary human cardiovascular RCT. 100 mg/day appears effective for blood pressure-lowering.
Cholesterol and Lipid Modulation
The Riche 2013 trial and follow-up analyses showed pterostilbene reduced total cholesterol and LDL while tending to increase HDL. Effect was more pronounced in subjects not on statin therapy. LDL reduction of approximately 6–15 mg/dL was seen in several analyses.
Cognitive and Neuroprotective
Animal studies show pterostilbene increases BDNF (brain-derived neurotrophic factor), reduces neuroinflammation, and improves working memory better than resveratrol in aged animals. Human cognitive data is very limited — one study combined with resveratrol showed cognitive improvement in older adults, but pterostilbene-specific human cognitive RCTs are lacking.
AMPK Activation and Longevity Pathways
Pterostilbene activates AMPK (the same energy-sensing kinase activated by caloric restriction and metformin) and SIRT1 sirtuin. These are mechanistic longevity pathway activations. Whether these translate to meaningful human longevity or healthspan benefits is unknown — this is the primary basis for pterostilbene's anti-aging interest.
Supplement forms compared
| Form | Typical dose / Bioavailability | Best for | Notes |
|---|---|---|---|
| Form | Dose | Best For | Notes |
| Trans-Pterostilbene Capsules | 50–250 mg/day | Cardiovascular and cognitive support — standard supplement form | Most clinical research used 50 mg twice daily; 100–250 mg/day common in longevity stacks |
| Pterostilbene + Resveratrol Combination | Ptero 50 mg + Resv 20 mg twice daily | Complementary stilbene pairing — different SIRT1/AMPK potency profiles | Rationale: pterostilbene has better bioavailability; resveratrol has more human trial data |
| Blueberry Extract (whole-food source) | Varies | Low-dose natural pterostilbene alongside other anthocyanins | Much lower pterostilbene content than supplements; not equivalent to clinical doses |
How much should you take?
- 50–100 mg twice daily pterostilbene is the most clinically studied dose range
- For blood pressure: 100 mg/day minimum based on Riche RCT showing -7.8 mmHg systolic
- Combine with resveratrol in a stilbene stack for complementary mechanisms
- Long-term use (3–6+ months) for cardiovascular and longevity applications
Trans-pterostilbene (synthetic form chemically identical to natural) is used in virtually all supplements. Look for minimum 98% purity. Third-party testing confirmation is valuable. Pterostilbene combined with resveratrol in a 1:1 ratio by some manufacturers may provide complementary SIRT activation pathways.
Safety and side effects
Common side effects
- Generally well-tolerated in human trials at 50–250 mg/day
- The Riche 2013 trial noted a possible LDL increase in a subgroup on metformin at higher doses (250 mg/day) — not replicated consistently
- Potential estrogen receptor modulation at very high doses — theoretical concern for hormone-sensitive conditions at non-clinical doses
- No significant safety signals in 6–8 week human trials
Serious risks
Pterostilbene has an excellent short-term safety profile in human trials. Long-term safety data beyond 12 weeks is limited. As an estrogenic compound (stilbene class), theoretical concerns exist for hormone-sensitive conditions at very high concentrations — not established as a clinical concern at standard supplement doses.
Drug and nutrient interactions
- Blood pressure medications — additive hypotensive effect possible; monitor
- Statins — possible additive LDL reduction; monitor lipids if combining
- Warfarin — stilbenes may modestly affect CYP2C9 metabolism of warfarin; monitor INR
- Tamoxifen and aromatase inhibitors — theoretical estrogenic modulation; consult oncologist
Check our free interaction checker for additional combinations.
Who might benefit — and who should use caution
| Most likely to benefit | Use with caution or seek guidance |
|---|---|
| Cardiovascular health-focused individuals seeking natural blood pressure and LDL support | People on hormone-sensitive cancer treatments — estrogenic activity; consult oncologist |
| Longevity-focused individuals interested in AMPK and sirtuin activation with better bioavailability than resveratrol | Those expecting extensive human clinical evidence — pterostilbene RCT base is thin (primarily one cardiovascular trial) |
| People already using resveratrol who want to add a bioavailable stilbene pairing | Women with BRCA mutations or hormone-sensitive breast cancer history — consult oncologist before use |
| Researchers and supplement enthusiasts tracking emerging longevity polyphenol science |
Frequently asked questions
How does pterostilbene compare to resveratrol?
The key difference is bioavailability: pterostilbene achieves ~80% oral bioavailability in animal models versus resveratrol's <1% (resveratrol undergoes rapid phase II glucuronidation and sulfation, reducing systemic exposure dramatically). This means much lower pterostilbene doses achieve similar or higher plasma concentrations. However, resveratrol has vastly more human clinical trial data — thousands of studies versus pterostilbene's handful. The comparison is: pterostilbene wins on pharmacokinetics; resveratrol wins on clinical evidence quantity.
Is pterostilbene found in blueberries?
Yes — blueberries are one of the primary natural sources, along with grapes and some barks. However, food amounts are very low: a cup of blueberries provides approximately 0.1 mg pterostilbene, while supplement doses are 50–250 mg. Eating blueberries provides pterostilbene plus anthocyanins, fiber, and other compounds, but at concentrations far below clinical supplement doses.
Can pterostilbene and resveratrol be combined?
Yes — they are often combined in longevity stacks because they activate overlapping but distinct sirtuin pathways and have complementary pharmacokinetic profiles (pterostilbene persists longer in tissues due to higher fat solubility). A common ratio is pterostilbene 50 mg + resveratrol 20 mg taken together. The David Sinclair longevity stack that popularized this combination uses this ratio.
Is pterostilbene safe long-term?
Short-term human trial data (6–8 weeks) shows good tolerability. Long-term data beyond 12 weeks is limited in humans. Given its structural similarity to resveratrol (which has been studied long-term), it is likely similarly safe at normal supplement doses. However, the estrogenic activity of stilbenes warrants caution in hormone-sensitive conditions for extended use.
Related ingredients
Resveratrol
Parent stilbene polyphenol with much more human evidence; lower bioavailability than pterostilbene.
Fisetin
Complementary flavonoid senolytic and AMPK activator for longevity stacks.
Quercetin
Broad-spectrum polyphenol with cardiovascular and anti-inflammatory evidence.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.